Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
Clinical trial NCT02143635 · COMPLETED
Trial details
- NCT number
- NCT02143635
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-07
- Primary completion
- 2017-06-20
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.